Zdrowie i gospodarka · 10/12/2021
FDA Releases Final Guidance on Postapproval Manufacturing Changes for Biological Products
The FDA has released a final guidance for industry on documenting postapproval manufacturing changes for specified biological products in annual reports, providing recommendations for holders of biologics license applications to ensure product safety and effectiveness.